Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on IFN-γ, IL-6, IL-17A, and IL-22 Production in PBMCs from Rheumatoid Arthritis Patients
Figure 1
(a) Synthetic route for Z-5-(5-bromo-2-metoxy-benzylidene)-3-(2-nitro-benzyl)-thiazolidine-2,4-dione (TM17). (b) Rosiglitazone chemical structure.
